ConductScience.org, home
FCGRT: Fc gamma receptor and transporter
API referenceFor AI assistants

Gene · 2217

Papers4,523

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

221 to 240 of 4,523

Download this page as JSON
TitleJournalYearPMIDFound bySource
Progress of neuroimmunotherapies: Witnessing an impressive success in the treatment of neurologic autoimmunities.Handb Clin Neurol202641526142PubTator, text miningPubMed
FcRn inhibitors: A new era in neurotherapeutics.Handb Clin Neurol202641526133PubTator, text miningPubMed
Pharmacological and speech-language pathology management of dysphagia in patients with myasthenia gravis.Naunyn Schmiedebergs Arch Pharmacol202641524776PubTator, text miningPubMed
Development and External Validation of a Multivariable Model to Predict Early Minimal Symptom Expression Response in Adult Generalized Myasthenia Gravis Patients Treated With Efgartigimod.CNS Neurosci Ther202641524248PubTator, text miningPubMed
Novel Therapies for Generalized Myasthenia Gravis: Insights Into FcRn and Complement Inhibition.Am J Ther202641505161PubTator, text miningPubMed
Risk of Infection Following Clearance of Immunoglobulin G by Plasma Exchange in Myasthenia Gravis.Muscle Nerve202641503688PubTator, text miningPubMed
Horizon scanning from panel discussions at the EUGOGO Global TED Forum 2025 London.Eye (Lond)202641501285PubTator, text miningPubMed
Preclinical evaluation of an antibody-based companion diagnostic for CD44v6 expressing cancer.Nucl Med Commun202641496609PubTator, text miningPubMed
Evolving Therapeutic Approaches for Treatment of Antibody-Mediated Rejection in Renal Allograft Recipients.Results Probl Cell Differ202641479029PubTator, text miningPubMed
In-Depth Profiling Highlights the Effect of Efgartigimod on Peripheral Innate and Adaptive Immune Cells in Myasthenia Gravis.Ann Clin Transl Neurol202641412962PubTator, text miningPubMed
A Rational Approach to Pharmacotherapy in Pregnancy.J Clin Pharmacol202641405555PubTator, text miningPubMed
A Tutorial on the Development of a Physiologically Inspired PKRO Model for Monoclonal Antibodies.CPT Pharmacometrics Syst Pharmacol202641390947PubTator, text miningPubMed
Olink Proteomics Analysis Reveals Heterogeneous Responses to FcRn Blockade in Anti-AChR Antibody-Positive Myasthenia Gravis: FGF-19 as a Novel Biomarker.Ann Clin Transl Neurol202641310415PubTator, text miningPubMed
Immunoglobulin G and Aging: Biological Functions and Its Crosstalk with the Gut Microbiota.Rejuvenation Res202641273130PubTator, text miningPubMed
Efgartigimod as Fast-Acting Rescue Therapy in Very Late-Onset Myasthenia Gravis.Neurol Ther202641258323PubTator, text miningPubMed
Expanding Evidence of Leptomeningeal Involvement in MOGAD and Its Relevance to Its Pathophysiology.Neurol Neuroimmunol Neuroinflamm202641252658PubTator, text miningPubMed
Limitations of rituximab in treating primary immune thrombocytopenia and the therapeutic potentials of alternatives.Curr Opin Hematol202641241968PubTator, text miningPubMed
Emerging therapies in idiopathic inflammatory myopathies.J Neuromuscul Dis202641129709PubTator, text miningPubMed
Blocking the neonatal Fc receptor as a novel approach to prevent cardiac neonatal lupus: a proof-of-concept study.Ann Rheum Dis202641111019PubTator, text miningPubMed
Novel therapeutics for immune thrombocytopenia: an evolving treatment landscape.Expert Rev Hematol202641036697PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Previous pageNext page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/2217/papers?page=12

API referenceFor AI assistants